OpenAlex

Works that cite this article, indexed by OpenAlex.

27 resultsUpdated October 25, 2026

← Back to article

The role of the gut microbiota in NAFLD

Nature Reviews Gastroenterology & Hepatology 13(7) (2016)

Christopher Leung; Leni R. Rivera; John B. Furness; Peter Angus

Non-alcoholic fatty liver disease, obesity and the metabolic syndrome

Best Practice & Research Clinical Gastroenterology 28(4) (2014)

Peter Dietrich; Claus Hellerbrand

Associations between dietary factors and markers of NAFLD in a general Dutch adult population

European Journal of Clinical Nutrition 72(1) (2017)

Annemarie Rietman; Diewertje Sluik; Edith J. M. Feskens; F.J. Kok; Marco Mensink

Flavonoid-Rich mulberry leaf extract modulate lipid metabolism, antioxidant capacity, and gut microbiota in high-fat diet-induced obesity: potential roles of FGF21 and SOCS2

Food & medicine homology. 1(2) (2024)

Yifan Liu; Nan Ling; Bing Zhang; Cong Chen; Xiao-Ning Mo; Jin-Yuan Cai; Xiangduan Tan; Qi-Ming Yu

Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease

Current Medicinal Chemistry 27(31) (2020)

Rodrigo Valenzuela; Macarena Ortíz; María Catalina Hernández‐Rodas; Francisca Echeverría; Luis Alberto Videla

Non-pharmacological management options for MAFLD: a practical guide

Therapeutic Advances in Endocrinology and Metabolism 14 (2023)

José Tadeu Stefano; Sebastião Mauro Bezerra Duarte; Renato Gama Altikes; Claudia Pinto Marques Souza de Oliveira

The Assessment and Management of Pain in Cirrhosis

Current Hepatology Reports 17(1) (2018)

Matthew J. Klinge; Tami Coppler; Jane M. Liebschutz; Mohannad F. Dugum; Ajay D. Wasan; Andrea F. DiMartini; Shari S. Rogal

Genome-based nutrition: An intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis

World Journal of Gastroenterology 21(12) (2015)

Sonia Román

Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta‐analysis of randomized controlled trials

Phytotherapy Research 33(3) (2019)

Reza Goodarzi; Kamran Sabzian; Farideh Shishehbor; Anahita Mansoori

International diet quality index and revised diet quality index relationship with non-alcoholic fatty liver disease: a case-control study

BMC Gastroenterology 23(1) (2023)

Narjes Najibi; Mitra Kazemi Jahromi; Farshad Teymoori; Hossein Farhadnejad; Ammar Salehi‐Sahlabadi; Parvin Mirmiran

Improving the economics of NASH/NAFLD treatment through the use of systems biology

Drug Discovery Today 22(10) (2017)

Jim Bosley; Christofer Boren; Sunjae Lee; Morten Grøtli; Jens Nielsen; Mathias Uhlén; Jan Borén; Adil Mardinoğlu

Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction

Peptides 125 (2019)

Farnaz Keyhani‐Nejad; Renate Luzía Barbosa-Yañez; Margrit Kemper; Rita Schüler; Olga Pivovarova‐Ramich; Natalia N. Rudovich; Andreas F. H. Pfeiffer

Effects of coenzyme Q10 supplementation on the anthropometric variables, lipid profiles and liver enzymes in patients with non-alcoholic fatty liver disease

Bangladesh Journal of Pharmacology 11(1) (2015)

Elnaz Jafarvand; Mahdieh Abbasalizad Farhangi; Beitullah Alipour; Manouchehr Khoshbaten

Compounding evidence implicating Western diets in the development of metabolic syndrome

Acta Physiologica 211(3) (2014)

Karen L. Sweazea

Impact of Dietary Niacin on Metabolic Dysfunction-Associated Steatotic Liver Disease in Mediterranean Subjects: A Population-Based Study

Nutrients 16(23) (2024)

Maria Antentas; Marina Idalia Rojo-López; Pau Vendrell; Minerva Granado-Casas; Idoia Genua; Berta Fernández‐Camins; Joana Rossell; Julia Niño-Narvión; Alejandra E. Moreira-Ramos; Esmeralda Castelblanco; Emilio Ortega; Bogdan Vlacho; Núria Alonso; Dı́dac Mauricio; Josep Julve